Lateral Flow Assays Market to Exceed US $7,900 Mn in 2022
With the advent of lateral flow assays, the testing has been brought away from the laboratory and closer to the patient. One of the major benefit of later flow assay testing is that it leads to early diagnosis, treatment and monitoring of health conditions. The healthcare industry has entered the era of rapid diagnostics, in which test results are almost instantaneous and accurate. Moreover, complex and costly equipment is not used in the lateral flow assays. Lateral flow assays uses...
View full press release